Benign Prostatic Hyperplasia Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Benign Prostatic Hyperplasia stocks.

Benign Prostatic Hyperplasia Stocks Recent News

Date Stock Title
May 3 PRCT PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q1 2024 Earnings Call Transcript
May 3 PRCT PROCEPT BioRobotics First Quarter 2024 Earnings: Beats Expectations
May 3 LLY Eli Lilly: Don't Overpay For Miracle Drugs
May 2 LLY 1 Wall Street Analyst Thinks Eli Lilly Stock Is Going to $892. Is It a Buy?
May 2 LLY Analysts reveal Eli Lilly stock price targets after earnings
May 2 LLY Weight Loss Competition Heats Up In Britain, Online Pharmacies Slash Prices for Wegovy and Mounjaro
May 2 LLY Amgen Soars After CEO Gives Update on Experimental Obesity Drug
May 2 LLY Market Chatter: Novo Nordisk, Eli Lilly's Weight-Loss Drugs Get Price Cuts in UK
May 2 LLY Weigh Loss Competition Heats Up In Britain, Online Pharmacies Slash Prices for Wegovy and Mounjaro
May 2 LLY Palatin gets FDA OK to test weight loss therapy with Eli Lilly’s tirzepatide
May 2 LLY Earnings Season: 3 Companies Boosting Guidance
May 2 BSX DENTSPLY SIRONA (XRAY) Q1 Earnings In Line, Revenues Decline Y/Y
May 2 LLY Novo Nordisk sales up 26% driven by GLP-1s, misses 11% on Wegovy
May 2 BSX Zimmer Biomet (ZBH) Q1 Earnings Beat, Margins Expand
May 2 BSX Envista (NVST) Q1 Earnings Miss Estimates, Margins Down
May 2 BSX Reasons to Retain Quest Diagnostics (DGX) Stock for Now
May 2 LLY Eli Lilly and Company (NYSE:LLY) Q1 2024 Earnings Call Transcript
May 2 BSX Baxter (BAX) Q1 Earnings Beat Estimates, '24 EPS View Raised
May 2 BSX Cardinal Health (CAH) Beats on Q3 Earnings, Ups '24 EPS View
May 2 LLY GLP-1 drug prices falling at UK pharmacies, clinics: report
Benign Prostatic Hyperplasia

Benign prostatic hyperplasia (BPH), also called prostate enlargement, is a noncancerous increase in size of the prostate. Symptoms may include frequent urination, trouble starting to urinate, weak stream, inability to urinate, or loss of bladder control. Complications can include urinary tract infections, bladder stones, and chronic kidney problems.The cause is unclear. Risk factors include a family history, obesity, type 2 diabetes, not enough exercise, and erectile dysfunction. Medications like pseudoephedrine, anticholinergics, and calcium channel blockers may worsen symptoms. The underlying mechanism involves the prostate pressing on the urethra thereby making it difficult to pass urine out of the bladder. Diagnosis is typically based on symptoms and examination after ruling out other possible causes.Treatment options including lifestyle changes, medications, a number of procedures, and surgery. In those with mild symptoms weight loss, exercise, and decreasing caffeine intake is recommended. In those with more significant symptoms medications may include alpha blockers such as terazosin or 5α-reductase inhibitors such as finasteride. Surgical removal of part of the prostate may be carried out in those who do not improve with other measures. Alternative medicine, such as saw palmetto, does not appear to help.About 105 million people are affected globally. BPH typically begins after the age of 40. Half of males age 50 and over are affected. After the age of 80 about 90% of males are affected. Although prostate specific antigen levels may be elevated in males with BPH, the condition does not increase the risk of prostate cancer.

Browse All Tags